NEW YORK (GenomeWeb News) – Tataa Biocenter today announced a deal to distribute Polyclone Bioservices' ePrime desktop application.

Tataa will also introduce the qPCR primer and probe design application in its qPCR courses as part of the deal.

ePrime allows for intuitive primer design experience "by adopting recent technology advancements in its new version (4.0) to highlight meaningful and valuable aspects of primer design," Göteborg, Sweden-based Tataa said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.